Skip to main content

Job opportunity for college students/recent grads

Below is an e-mail posted to the HPS Adults Yahoo! group today by Shirley. This is a great way to get a start working for the federal government. My brother Ryan is a former WRP intern. I thought I'd post not only for HPS'ers, but for everyone in the albinism community or low vision community that keeps up with the blog. Good luck!

P.S. This post is from a specific college. You should check with your own college's career development, job placement or disability services office.


The WRP is a recruitment and referral program that connects federal and private sector employers with highly motivated postsecondary students with disabilities who are eager to prove their abilities in the workplace through summer or permanent jobs.


In COSA we are coordinating CUNY's participation in this federal collaboration of the Office of Disability Employment Policy (ODEP), the U.S. Department of Defense (DOD) and the Department of Labor (DOL).

Applicants for the program must:

- have a disability AND

- be a U.S. citizen AND

- be enrolled in an accredited institution of higher education on a substantially full-time basis (unless the severity of the disability precludes the student from taking a substantially full-time load) to seek a degree OR

- be enrolled in such an institution as a degree-seeking student taking less than a substantially full-time load in the enrollment period immediately prior to graduation OR

- have graduated from such an institution within the past year.

Students who are interested in applying should contact Stephen Clark at Stephen.Clark@mail.cuny.edu. Interviews will be scheduled on October 19th, 20th, 21st and 22nd.

Your assistance with identifying students to participate is greatly appreciated. Attached please find a flier for distribution.

Regards,

Mavis

Mavis Hall
University Disability Service Programs
City University of New York
Central Office of Student Affairs
101 West 31st Street, 12th floor
New York, New York 10001
212-652-2051

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria